Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries

Craig S Broberg1, Alexandra van Dissel2, Jessica Minnier3

  • 1Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon, USA.

Insights

Adults with d-loop transposition of the great arteries (d-TGA) after atrial switch surgery face slow progression to heart failure. Key predictors for adverse outcomes include ventricular arrhythmia and heart failure admissions, aiding risk stratification.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Adult Congenital Heart Disease

Background:

  • Adults with d-loop transposition of the great arteries (d-TGA) and a systemic right ventricle post-atrial switch require risk assessment for end-stage heart failure.
  • Identifying factors predicting adverse outcomes is crucial for managing this complex patient population.

Purpose of the Study:

  • To determine factors associated with survival in a large cohort of adults with d-TGA and prior atrial switch surgery.
  • To identify predictors of end-stage heart failure outcomes in this population.

Main Methods:

  • A multicenter, retrospective cohort study of adults with d-TGA and prior atrial switch surgery.
  • Clinical data were collected from initial and most recent visits.
  • The composite primary outcome included death, transplantation, or mechanical circulatory support (MCS).

Main Results:

  • Over a median of 9.2 years, 91 out of 1,168 patients (8.8% per 10 person-years) experienced the primary outcome.
  • Sudden/arrhythmic death occurred at a younger age compared to other causes of death.
  • Independent 5-year predictors of adverse outcomes included prior ventricular arrhythmia, heart failure admission, complex anatomy, QRS duration >120 ms, and severe right ventricle dysfunction.

Conclusions:

  • The progression to end-stage heart failure or death is generally slow for most adults with d-TGA after atrial switch.
  • A simplified prediction score has been developed to identify individuals at the highest risk for adverse outcomes within a 5-year period.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
25
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
29
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
37